Poseida Therapeutics
Poseida Therapeutics develops targeted cell therapy founded in 2014 by Eric Ostertag.
5
Funding Rounds
$333.5m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Er** Os****** | - | - | linkedin twitter |
| Name | Phone | Social networks | |
|---|---|---|---|
| Er** Os****** | - | - | linkedin twitter |
| Jo** Sc**** | - | - | - |
| Cy***** Co***** | - | - | |
| Ma** J. Ge**** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Er** Os****** | - | - | linkedin twitter |
Funding
Funding series
Funding Series Analysis
The company Poseida Therapeutics has raised a total of $252m in funding over 5 rounds.
Key Insights:
- Poseida Therapeutics , June 2020: $110m
- Poseida Therapeutics Series C round, April 2019: $142m
- Poseida Therapeutics, Inc. funding round, August 2017: $15m
- Poseida Therapeutics funding round, April 2018: $30.5m
- Poseida Therapeutics, Inc. funding round, December 2015: $36.03m
Poseida Therapeutics , June 2020
$110m
Poseida Therapeutics Series C round, April 2019
$142m
Poseida Therapeutics, Inc. funding round, August 2017
$15m
Poseida Therapeutics funding round, April 2018
$30.5m
Poseida Therapeutics, Inc. funding round, December 2015
$36.03m
Industries
Poseida Therapeutics is active in the following industries:
- Immunotherapy
- Cell therapy
- Therapeutics
- Biomedical engineering
- Technology
- Synthetic biology
- Biology
- Biotechnology
- Healthcare
- Regenerative medicine
- Genomics
- Genome editing
- Tissue engineering
- Speciality chemicals
- Engineering
- Allogeneic cell therapy
- Genetic engineering
- T cell
- CAR T-Cell therapy